Search
Kuihua Pharmaceutical Announces Acceptance of Vitamin K1 Drops for Listing Approval
6 day ago /
Read about 0 minute
Author：小编
Kuihua Pharmaceutical is pleased to announce that its subsidiary, Kuihua Pharmaceutical Group (Xiangyang) Longzhong Co., Ltd., has received a notification from the National Medical Products Administration, accepting the registration and listing approval of Vitamin K1 Drops. These drops are specifically designed to prevent vitamin K deficiency bleeding in infants. The company is committed to actively facilitating the listing approval process and will closely monitor its progress.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
